Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
30,794,820
-
Share change
-
-3,193,681
-
Total reported value
-
$98,563,792
-
Put/Call ratio
-
63%
-
Price per share
-
$3.20
-
Number of holders
-
114
-
Value change
-
-$20,795,950
-
Number of buys
-
49
-
Number of sells
-
61
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q3 2024
As of 30 Sep 2024,
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,794,820 shares.
The largest 10 holders included
CAS Investment Partners, LLC, BlackRock, Inc., VANGUARD GROUP INC, 683 Capital Management, LLC, KPS Global Asset Management UK Ltd, WORLDLY PARTNERS MANAGEMENT, LLC, BRIGHTLIGHT CAPITAL MANAGEMENT LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and MARSHALL WACE, LLP.
This page lists
109
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.